YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	Pandemics extend beyond infectious diseases: the emerging threat of non-communicable diseases	KOREAN JOURNAL OF INTERNAL MEDICINE
2025	Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study	CLINICAL HYPERTENSION
2025	Effectiveness of Radiation Shields to Minimize Operator Dose in the Bronchoscopy Suite: A Phantom Study and Clinical Application	JOURNAL OF CLINICAL MEDICINE
2025	Endovascular Aneurysmal Repair With the INCRAFT Stent Graft System for Abdominal Aortic Aneurysms: A Combined Korean Multi-Center and Single-Center Registry Analysis	JOURNAL OF ENDOVASCULAR THERAPY
2025	Preserving Informative Presence: How Missing Data and Imputation Strategies Affect the Performance of an AI-Based Early Warning Score	JOURNAL OF CLINICAL MEDICINE
2025	Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial	LANCET GASTROENTEROLOGY & HEPATOLOGY
2025	Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 Diabetes	JOURNAL OF CLINICAL MEDICINE
2025	Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study	LANCET ONCOLOGY
2025	Clinical outcomes according to the average daily dose of sacubitril/valsartan: a nationwide longitudinal cohort study	CLINICAL RESEARCH IN CARDIOLOGY
2025	Risk factors and transitional probability of clinical events in Korean CKD patients using the multistate model	SCIENTIFIC REPORTS
2025	Exploring the Therapeutic Potential of Cordyceps Mushroom on SARS-CoV-2 Using Virtual Screening against Mproand In Vitro Validation of Cordycepin	JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
2025	Association Between HLA-B5801 Positivity and Patient Characteristics and Clinical Outcomes in Gout	IN VIVO
2025	Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation	BMC INFECTIOUS DISEASES
2025	Urine Leukocyte Counts for Differentiating Asymptomatic Bacteriuria From Urinary Tract Infection and Predicting Secondary Bacteremia	JOURNAL OF KOREAN MEDICAL SCIENCE
2025	Prognostic Value of Residual Circulating Tumor DNA in Metastatic Pancreatic Ductal Adenocarcinoma	ANNALS OF LABORATORY MEDICINE
2025	Changes of Clinical Practice Patterns of Allergen Immunotherapy in Korea	ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
2025	Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study	BREAST CANCER RESEARCH
2025	Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021	JHEP REPORTS
2025	Elevated Soluble Suppressor of Tumorigenicity 2 Levels in Gout Patients and Its Association with Cardiovascular Disease Risk Indicators	YONSEI MEDICAL JOURNAL
2025	Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)	DIABETES & METABOLISM JOURNAL